An improved targeted vaccine strategy against anthrax

$255,409U54FY2008AINIH

Harvard Medical School, Boston MA

Investigators

Ronald K Taylorcontact

Linked publications, trials & patents

Paper 38680558 Paper 37780364 Paper 37662211 Paper 37610224 Paper 34417313 Paper 33408184 Paper 33319995 Paper 32987745 Paper 32603593 Paper 32364380 Paper 32348107 Paper 31914414 Paper 31809018 Paper 30395379 Paper 29937406 Paper 28871080 Paper 28781126 Paper 28706631 Paper 28698673 Paper 28658630 Paper 28400473 Paper 28034743 Paper 27992879 Paper 27911388 Paper 27672120 Paper 27579370 Paper 27572444 Paper 27539858 Paper 27539384 Paper 27336950 Paper 27193679 Paper 27105280 Paper 27101010 Paper 26980837 Paper 26919416 Paper 26912630 Paper 26910435 Paper 26872864 Paper 26840427 Paper 26807441 Paper 26747103 Paper 26740390 Paper 26707217 Paper 26701099 Paper 26619249 Paper 26613408 Paper 26549784 Paper 26510153 Paper 26473364 Paper 26396190 Paper 26392509 Paper 26216419 Paper 26195743 Paper 26192320 Paper 26191658 Paper 26178180 Paper 26144317 Paper 26078454 Paper 26041296 Paper 26039584 Paper 25987613 Paper 25866377 Paper 25851602 Paper 25778700 Paper 25641385 Paper 25599080 Paper 25583731 Paper 25578459 Paper 25564615 Paper 25479384 Paper 25404023 Paper 25317832 Trial NCT00565929 Trial NCT00133575 Patent 9885088 Patent 9879003 Patent 9834616 Patent 9676763 Patent 9616116 Patent 9533032 Patent 9452992 Patent 9359275 Patent 9340505 Patent 9271972 Patent 9234885 Patent 9216223 Patent 9193705 Patent 9131687 Patent 9023352 Patent 8865169 Patent 8841253 Patent 8716283 Patent 8642042 Patent 8617838 Patent 8609663 Patent 8598342 Patent 8349326 Patent 8232240 Patent 7807180 Patent 7517667

View original record on NIH RePORTER →